by Ket Patel | Mar 28, 2012 | All Articles For Neurology, Alzheimer's Disease
Monitoring for metabolic side effects proved to be infrequent for outpatients with dementia or delirium who had been prescribed antipsychotic medications at 32 Veterans Affairs medical centers. Antipsychotic medications are approved by the Food and Drug Administration...
by Ket Patel | Mar 24, 2012 | All Articles For Neurology, Neuro-Oncology
Electrocutaneous direct nerve stimulation via a device that scrambles “pain” and “no pain” signals reduced pain scores in preliminary studies involving patients with refractory chemotherapy-induced peripheral neuropathy, post-herpetic...
by Ket Patel | Mar 18, 2012 | All Articles For Neurology, Stroke
Levels of air pollution that fall within the amounts deemed safe in current U.S. standards for air quality were associated with a significant increase the risk for acute ischemic stroke after short-term exposure and accelerated cognitive decline after long-term...
by Ket Patel | Mar 17, 2012 | All Articles For Neurology, Stroke
Two new risk assessment scores predicted the likelihood of a symptomatic intracranial hemorrhage after ischemic stroke treatment with more than 70% accuracy. Predictive rules such as these are important because there is still no large-scale prospective study that...
by Ket Patel | Mar 16, 2012 | All Articles For Neurology, Stroke
A granulocyte colony-stimulating drug did not protect brain tissue or improve functional outcomes after ischemic stroke. Researchers had high hopes for filgrastim, which is approved in Europe for chemotherapy-induced neutropenia. In vivo and in vitro studies indicated...
